Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-09-25

FDA Approved: FOSPHENYTOIN SODIUM — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approved a supplemental application for fosphenytoin sodium by Hikma Pharmaceuticals USA Inc., approving changes to the approved product under an existing A…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fosphenytoin Sodium (fosphenytoin sodium)

Snippet

SUPPL AP for FOSPHENYTOIN SODIUM (FOSPHENYTOIN SODIUM)